• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种带有辅助蛋白缺失的活减 SARS-CoV-2 疫苗候选物。

A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions.

机构信息

Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.

Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.

出版信息

Nat Commun. 2022 Jul 27;13(1):4337. doi: 10.1038/s41467-022-31930-z.

DOI:10.1038/s41467-022-31930-z
PMID:35896528
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9326133/
Abstract

We report a live-attenuated SARS-CoV-2 vaccine candidate with (i) re-engineered viral transcription regulator sequences and (ii) deleted open-reading-frames (ORF) 3, 6, 7, and 8 (∆3678). The ∆3678 virus replicates about 7,500-fold lower than wild-type SARS-CoV-2 on primary human airway cultures, but restores its replication on interferon-deficient Vero-E6 cells that are approved for vaccine production. The ∆3678 virus is highly attenuated in both hamster and K18-hACE2 mouse models. A single-dose immunization of the ∆3678 virus protects hamsters from wild-type virus challenge and transmission. Among the deleted ORFs in the ∆3678 virus, ORF3a accounts for the most attenuation through antagonizing STAT1 phosphorylation during type-I interferon signaling. We also developed an mNeonGreen reporter ∆3678 virus for high-throughput neutralization and antiviral testing. Altogether, the results suggest that ∆3678 SARS-CoV-2 may serve as a live-attenuated vaccine candidate and a research tool for potential biosafety level-2 use.

摘要

我们报告了一种具有(i)经过重新设计的病毒转录调节剂序列和(ii)缺失开放阅读框(ORF)3、6、7 和 8(∆3678)的 SARS-CoV-2 减毒活疫苗候选物。与野生型 SARS-CoV-2 相比,∆3678 病毒在原代人呼吸道培养物中的复制低约 7500 倍,但在获准用于疫苗生产的干扰素缺陷型 Vero-E6 细胞中恢复其复制。∆3678 病毒在仓鼠和 K18-hACE2 小鼠模型中均高度减毒。单次免疫∆3678 病毒可保护仓鼠免受野生型病毒攻击和传播。在∆3678 病毒中缺失的 ORF 中,ORF3a 通过在 I 型干扰素信号传导过程中拮抗 STAT1 磷酸化,导致最大程度的衰减。我们还开发了一种 mNeonGreen 报告∆3678 病毒,用于高通量中和和抗病毒测试。总之,这些结果表明,∆3678 SARS-CoV-2 可能成为一种减毒活疫苗候选物和潜在生物安全二级用途的研究工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e772/9329368/881e6f62dac8/41467_2022_31930_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e772/9329368/8eed686c07ff/41467_2022_31930_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e772/9329368/03c8d6ad5f4d/41467_2022_31930_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e772/9329368/0172341ab0f7/41467_2022_31930_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e772/9329368/36e2e0c8abd3/41467_2022_31930_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e772/9329368/911761ec132b/41467_2022_31930_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e772/9329368/881e6f62dac8/41467_2022_31930_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e772/9329368/8eed686c07ff/41467_2022_31930_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e772/9329368/03c8d6ad5f4d/41467_2022_31930_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e772/9329368/0172341ab0f7/41467_2022_31930_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e772/9329368/36e2e0c8abd3/41467_2022_31930_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e772/9329368/911761ec132b/41467_2022_31930_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e772/9329368/881e6f62dac8/41467_2022_31930_Fig6_HTML.jpg

相似文献

1
A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions.一种带有辅助蛋白缺失的活减 SARS-CoV-2 疫苗候选物。
Nat Commun. 2022 Jul 27;13(1):4337. doi: 10.1038/s41467-022-31930-z.
2
A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions.一种缺失辅助蛋白的减毒活新冠病毒候选疫苗。
bioRxiv. 2022 Feb 15:2022.02.14.480460. doi: 10.1101/2022.02.14.480460.
3
Immunization with Recombinant Accessory Protein-Deficient SARS-CoV-2 Protects against Lethal Challenge and Viral Transmission.用重组缺失辅助蛋白的 SARS-CoV-2 进行免疫接种可预防致死性挑战和病毒传播。
Microbiol Spectr. 2023 Jun 15;11(3):e0065323. doi: 10.1128/spectrum.00653-23. Epub 2023 May 16.
4
Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice.SARS-CoV-2 辅助蛋白对 K18 人 ACE2 转基因小鼠病毒致病性的贡献。
J Virol. 2021 Aug 10;95(17):e0040221. doi: 10.1128/JVI.00402-21.
5
A single intranasal dose of a live-attenuated parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in hamsters.单剂量鼻内接种减毒活副流感病毒载体的SARS-CoV-2疫苗对仓鼠具有保护作用。
Proc Natl Acad Sci U S A. 2021 Dec 14;118(50). doi: 10.1073/pnas.2109744118.
6
The Cold-Adapted, Temperature-Sensitive SARS-CoV-2 Strain TS11 Is Attenuated in Syrian Hamsters and a Candidate Attenuated Vaccine.适应寒冷、温度敏感的 SARS-CoV-2 株 TS11 在叙利亚仓鼠中减毒,是一种候选减毒疫苗。
Viruses. 2022 Dec 29;15(1):95. doi: 10.3390/v15010095.
7
Single Immunization with Recombinant ACAM2000 Vaccinia Viruses Expressing the Spike and the Nucleocapsid Proteins Protects Hamsters against SARS-CoV-2-Caused Clinical Disease.单次免疫表达刺突蛋白和核衣壳蛋白的重组 ACAM2000 痘苗病毒可保护仓鼠免受 SARS-CoV-2 引起的临床疾病。
J Virol. 2022 May 11;96(9):e0038922. doi: 10.1128/jvi.00389-22. Epub 2022 Apr 12.
8
A Methyltransferase-Defective Vesicular Stomatitis Virus-Based SARS-CoV-2 Vaccine Candidate Provides Complete Protection against SARS-CoV-2 Infection in Hamsters.一种甲基转移酶缺陷型水疱性口炎病毒基于 SARS-CoV-2 疫苗候选物可在仓鼠中提供针对 SARS-CoV-2 感染的完全保护。
J Virol. 2021 Sep 27;95(20):e0059221. doi: 10.1128/JVI.00592-21. Epub 2021 Aug 11.
9
A single-dose intranasal live-attenuated codon deoptimized vaccine provides broad protection against SARS-CoV-2 and its variants.单剂鼻内接种减毒活疫苗可提供针对 SARS-CoV-2 及其变体的广泛保护。
Nat Commun. 2024 Aug 26;15(1):7225. doi: 10.1038/s41467-024-51535-y.
10
Live-attenuated YF17D-vectored COVID-19 vaccine protects from lethal yellow fever virus infection in mouse and hamster models.减毒活 YF17D 载体 COVID-19 疫苗可预防小鼠和仓鼠模型中的致死性黄热病病毒感染。
EBioMedicine. 2022 Sep;83:104240. doi: 10.1016/j.ebiom.2022.104240. Epub 2022 Aug 27.

引用本文的文献

1
Influence of Sex and 1,25α Dihydroxyvitamin D on SARS-CoV-2 Infection and Viral Entry.性别与1,25α-二羟维生素D对新型冠状病毒2型感染及病毒进入的影响
Pathogens. 2025 Aug 2;14(8):765. doi: 10.3390/pathogens14080765.
2
COVID-19-associated neuroinflammation and astrocyte death in the brain linked to ORF3a-induced activation of Sur1-mediated ion channels.与COVID-19相关的脑部神经炎症和星形胶质细胞死亡与ORF3a诱导的Sur1介导的离子通道激活有关。
mBio. 2025 Aug 13:e0201225. doi: 10.1128/mbio.02012-25.
3
Development of the coronavirus reverse genetic system: Core technology for pathogenesis mechanisms research and vaccine/drug development.

本文引用的文献

1
Multiple spillovers from humans and onward transmission of SARS-CoV-2 in white-tailed deer.人类向白尾鹿多次溢出 SARS-CoV-2 并发生传播。
Proc Natl Acad Sci U S A. 2022 Feb 8;119(6). doi: 10.1073/pnas.2121644119.
2
The N501Y spike substitution enhances SARS-CoV-2 infection and transmission.N501Y 刺突突变增强了 SARS-CoV-2 的感染和传播。
Nature. 2022 Feb;602(7896):294-299. doi: 10.1038/s41586-021-04245-0. Epub 2021 Nov 24.
3
Mouse-adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge.鼠适应的 SARS-CoV-2 可保护动物免受致死性 SARS-CoV 攻击。
冠状病毒反向遗传系统的发展:发病机制研究及疫苗/药物研发的核心技术
Virulence. 2025 Dec;16(1):2525930. doi: 10.1080/21505594.2025.2525930. Epub 2025 Jun 28.
4
Evolving SARS-CoV-2 Vaccines: From Current Solutions to Broad-Spectrum Protection.不断演变的新冠病毒疫苗:从当前解决方案到广谱保护
Vaccines (Basel). 2025 Jun 12;13(6):635. doi: 10.3390/vaccines13060635.
5
Protective Potential and Functional Role of Antibodies Against SARS-CoV-2 Nucleocapsid Protein.抗SARS-CoV-2核衣壳蛋白抗体的保护潜力及功能作用
Antibodies (Basel). 2025 May 28;14(2):45. doi: 10.3390/antib14020045.
6
Engineering a recombination-resistant live attenuated vaccine candidate with suppressed interferon antagonists for PEDV.构建一种具有抗重组能力的猪流行性腹泻病毒(PEDV)减毒活疫苗候选株,其干扰素拮抗剂功能被抑制。
J Virol. 2025 Jul 22;99(7):e0045125. doi: 10.1128/jvi.00451-25. Epub 2025 Jun 12.
7
Determination of resilience of a panel of broadly neutralizing mAbs to emerging variants of SARS-CoV-2 generated using reverse genetics.利用反向遗传学技术对一组广泛中和性单克隆抗体针对新冠病毒(SARS-CoV-2)新出现变异株的抗性进行测定。
iScience. 2025 Apr 16;28(6):112451. doi: 10.1016/j.isci.2025.112451. eCollection 2025 Jun 20.
8
Live attenuated SARS-CoV-2 vaccine OTS-228 demonstrates efficacy, safety, and stability in preclinical model.减毒活新冠病毒疫苗OTS-228在临床前模型中显示出有效性、安全性和稳定性。
NPJ Vaccines. 2025 May 23;10(1):104. doi: 10.1038/s41541-025-01165-2.
9
SARS-CoV-2 virus lacking the envelope and membrane open-reading frames as a vaccine platform.缺乏包膜和膜开放阅读框的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒作为一种疫苗平台
Nat Commun. 2025 May 14;16(1):4453. doi: 10.1038/s41467-025-59533-4.
10
Comparative analysis of replication and immune evasion among SARS-CoV-2 subvariants BA.2.86, JN.1, KP.2, and KP.3.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)亚型BA.2.86、JN.1、KP.2和KP.3的复制与免疫逃逸比较分析
mBio. 2025 Apr 29:e0350324. doi: 10.1128/mbio.03503-24.
PLoS Biol. 2021 Nov 4;19(11):e3001284. doi: 10.1371/journal.pbio.3001284. eCollection 2021 Nov.
4
ORF3a Protein of Severe Acute Respiratory Syndrome Coronavirus 2 Inhibits Interferon-Activated Janus Kinase/Signal Transducer and Activator of Transcription Signaling Elevating Suppressor of Cytokine Signaling 1.严重急性呼吸综合征冠状病毒2的ORF3a蛋白抑制干扰素激活的Janus激酶/信号转导子和转录激活子信号通路,上调细胞因子信号转导抑制因子1。
Front Microbiol. 2021 Sep 28;12:752597. doi: 10.3389/fmicb.2021.752597. eCollection 2021.
5
Replication and single-cycle delivery of SARS-CoV-2 replicons.SARS-CoV-2 复制子的复制和单周期传递。
Science. 2021 Nov 26;374(6571):1099-1106. doi: 10.1126/science.abj8430. Epub 2021 Oct 14.
6
Animal reservoirs of SARS-CoV-2: calculable COVID-19 risk for older adults from animal to human transmission.动物是 SARS-CoV-2 的宿主:动物传播给人类,老年人面临可计算的 COVID-19 风险。
Geroscience. 2021 Oct;43(5):2305-2320. doi: 10.1007/s11357-021-00444-9. Epub 2021 Aug 30.
7
Could live attenuated vaccines better control COVID-19?活疫苗能否更好地控制 COVID-19?
Vaccine. 2021 Sep 15;39(39):5719-5726. doi: 10.1016/j.vaccine.2021.08.018. Epub 2021 Aug 11.
8
SARS-CoV-2 natural infection in animals: a systematic review of studies and case reports and series.动物中 SARS-CoV-2 的自然感染:研究和病例报告及系列的系统评价。
Vet Q. 2021 Dec;41(1):250-267. doi: 10.1080/01652176.2021.1970280.
9
Cryo-EM structure of SARS-CoV-2 ORF3a in lipid nanodiscs.冷冻电镜结构解析 SARS-CoV-2 ORF3a 在脂质纳米盘中的结构。
Nat Struct Mol Biol. 2021 Jul;28(7):573-582. doi: 10.1038/s41594-021-00619-0. Epub 2021 Jun 22.
10
Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice.SARS-CoV-2 辅助蛋白对 K18 人 ACE2 转基因小鼠病毒致病性的贡献。
J Virol. 2021 Aug 10;95(17):e0040221. doi: 10.1128/JVI.00402-21.